Company / Depreciation & Amortization
Innoviva, Inc. Depreciation & Amortization History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$13.8M
FY2021
5-year range
$13.8M / $13.8M
FY2017-FY2021
Trend
-0.1%
vs FY2020
Sector context
#56 of 163
Health Care
What the data says
At $14M, Innoviva, Inc.'s depreciation & amortization ranks #108 of 163 in the Health Care sector. Depreciation & Amortization remained relatively stable over the past 6 years, with values between $14M and $14M.
Based on SEC 10-K filings.
$14M in FY2021 with a 5-year CAGR of -0.2%.
Remained stable around $14M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -0.3%
- 5-Year CAGR
- -0.2%
- 10-Year CAGR
- -
Sector benchmark
#108 of 163 in Health CareTop 66% of 163This company $13.8M Sector average $219.4M
▼
-93.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -0.2%, indicating a declining trend.
- In FY2021, depreciation & amortization decreased 0.1% year-over-year.
- Ranks #56 out of 163 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $13.8M | -0.1% |
| FY2020 | $13.8M | -1.0% |
| FY2019 | $14.0M | +0.2% |
| FY2018 | $14.0M | -0.2% |
| FY2017 | $14.0M | +0.2% |
| FY2016 | $14.0M | +0.2% |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026